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Abstract
Rationale and Objective—To determine the relationship between screening mammography 
facility characteristics and on-site availability of advanced breast imaging services required for 
supplemental screening and the diagnostic evaluation of abnormal screening findings.
Materials and Methods—We analyzed data from all active imaging facilities across six 
regional registries of the National Cancer Institute-funded Breast Cancer Surveillance Consortium 
offering screening mammography in calendar years 2011–2012 (n=105). We used generalized 
estimating equations regression models to identify associations between facility characteristics 
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(e.g., academic affiliation, practice type) and availability of on-site advanced breast imaging (e.g., 
ultrasound, magnetic resonance imaging (MRI)) and image-guided biopsy services.
Results—Breast MRI was not available at any non-radiology or breast imaging only facilities. A 
combination of breast US, breast MRI, and imaging-guided breast biopsy services was available at 
76.0% of multi-specialty breast centers compared to 22.2% of full diagnostic radiology practices 
(p=0.0047) and 75.0% of facilities with academic affiliations compared to 29.0% of those without 
academic affiliations (p=0.04). Both supplemental screening breast ultrasound and screening 
breast MRI were available at 28.0% of multi-specialty breast centers compared to 4.7% of full 
diagnostic radiology practices (p<0.01) and 25.0% of academic facilities compared to 8.5% of 
non-academic facilities (p=0.02).
Conclusion—Screening facility characteristics are strongly associated with the availability of 
on-site advanced breast imaging and image-guided biopsy service. Therefore, the type of imaging 
facility a woman attends for screening may have important implications on her timely access to 
supplemental screening and diagnostic breast imaging services.
Keywords
Screening; breast cancer; mammography; diagnostic imaging
INTRODUCTION
Inherent health system attributes, such as place of service, strongly influence both access to 
and quality of healthcare in the U.S.1–4 For women undergoing routine breast cancer 
screening in the U.S., both access to and quality of breast imaging services varies widely.5–9 
For women with an abnormal screening result, timely and complete diagnostic imaging 
evaluation is a critical, intermediate step between screen-detected malignancy and definitive 
treatment.10,11 Appropriate diagnostic breast imaging frequently requires modalities beyond 
mammography, including diagnostic breast ultrasound (US), image-guided breast biopsy, 
and breast magnetic resonance imaging (MRI)(e.g., for extent of disease and surgical 
planning).12 Patient access to and ready availability of these advanced breast imaging 
modalities, therefore, may play an important role in preventing delays in diagnostic 
evaluation and, potentially, worse patient outcomes.13,14
Over the last decade, technological advances in breast imaging modalities, including higher 
resolution breast US and breast MRI, along with expansion of their clinical indications, have 
caused the rapid diffusion of these technologies into community practices.15 However, the 
diffusion and adoption of these advanced imaging modalities may not occur based on patient 
need, including high lifetime breast cancer risk.16 Moreover, the demand for more advanced 
breast imaging is likely to increase with new breast density reporting laws enacted by states 
across the U.S.17 These laws mandate that imaging facilities inform women with 
mammographically dense breasts that they are at increased risk of developing cancer and 
some also require notification that they may benefit from supplemental screening.18 For 
women at increased risk of developing cancer, both screening breast US and screening MRI 
have been found to increase cancer detection beyond mammography alone, and annual 
screening breast MRI is a cost-effective measure among women at very high breast cancer 
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risk.19,20 Utilization of breast MRI is also increasing among women with a personal history 
of breast cancer for routine surveillance.16
Thus, for both women who seek an imaging facility that can provide diagnostic breast 
imaging or biopsy on-site if a screening abnormality is detected and for women who seek 
supplemental screening beyond mammography, it would be helpful to know what types of 
imaging facilities are more likely to offer advanced breast imaging services. Our study 
objective was to describe the current advanced breast imaging availability at U.S. 
community-based imaging facilities based on their characteristics, including for-profit 
status, academic affiliation, and practice type. Specifically, we aimed to determine the 
relationship between facility-level characteristics and the availability of breast US, breast 
MRI, and image-guided breast biopsies, alone and in combination, among a national sample 
of U.S. community imaging facilities that offer screening mammography.
MATERIALS AND METHODS
Study Population
We obtained data from a large cohort of active imaging facilities that are included in the 
National Cancer Institute-funded Breast Cancer Surveillance Consortium (BCSC), a 
collaborative network of mammography registries that represent the largest national 
database regarding breast cancer screening (http://breastscreening.cancer.gov). The 
population served by the BCSC has been shown to be comparable to the U.S. population.5,21 
We analyzed pooled data sent to the BCSC Statistical Coordinating Center (SCC) during 
calendar years 2011 and 2012, from six registries (New Hampshire, North Carolina, San 
Francisco, Vermont, Chicago, and Western Washington). Each registry and the SCC 
received institutional review board approval for either active or passive consenting processes 
or a waiver of consent to enroll individual facilities, link data, and perform analytic studies. 
All procedures were Health Insurance Portability and Accountability Act (HIPAA) 
compliant, and each registry and the SCC received federal certificates of confidentiality and 
other protections for the identities of individual community facilities.
Data Collection
Each of the six registries obtained data from their respective BCSC-affiliated imaging 
facilities that offer screening mammography. Individual fixed-location facilities self-
reported their data on the availability of advanced breast imaging modalities beyond 
mammography, as well as image-guided breast biopsy services for calendar years 2011–
2012. Imaging data included the availability of breast US (for screening and any indication), 
breast MRI (for screening and any indication), stereotactic core breast biopsy, US-guided 
core breast biopsy, and MRI-guided core breast biopsy.
Individual facilities reported their academic medical center affiliation (if any), their for-
profit versus not-for-profit status, and their practice type. For practice type, we categorized 
each stand-alone facility as a non-radiology practice, breast imaging only practice, full 
diagnostic radiology practice, or a multi-specialty breast center. Each facility was asked to 
select a single practice type that best described them. We defined a non-radiology practice as 
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an imaging facility located within and operated by a different specialty (e.g., obstetrics and 
gynecology clinic). We defined a breast imaging only practice as a facility that only offers 
imaging services specific to the breasts and no other anatomic body part. We defined a full 
diagnostic radiology practice as one that offers imaging services for multiple anatomic body 
parts beyond the breasts. Finally, we considered a multi-specialty breast center to be a 
facility that is part of an integrated care center with on-site breast-specific specialists in 
addition to radiologists (e.g., a cancer center with on-site breast oncologists, breast radiation 
oncologists, and breast pathologists).
Statistical Analysis
We performed statistical analyses using SAS version 9.3 (SAS Institute, Cary, NC) and 
Stata version 12 (Statacorp LP, College Station, TX). We tabulated the distribution of 
facility characteristics (for-profit status, academic affiliation, and practice type). We then 
used generalized estimating equations (GEE) to calculate the proportion of facilities of each 
profit status, academic affiliation, and practice type that provided advanced breast imaging 
services. Specifically, we examined the availability of breast US (for screening or any 
indication), breast MRI (for screening or any indication), image-guided breast biopsy 
(stereotactic, US-guided, MRI-guided, and any imaging-guided), and combinations of 
advanced breast imaging and image-guided breast biopsy services by facility characteristics. 
Each model regressed a binary indicator of service provision on dummy variables for the 
facility characteristic of interest. Our GEE models accommodated correlation among 
individual fixed-location facilities belonging to the same imaging group practice (e.g., 
multiple fixed-location facilities affiliated with one another and/or under the same 
management) through the use of the robust Huber-White (sandwich) variance estimator.22 
We obtained predicted probabilities from each model and estimated 95% confidence bounds 
around each probability estimate via the delta method. Confidence bounds were not 
calculated for probability estimates of exactly zero or one. We report p-values based on the 
joint Wald test of model parameters associated with the facility characteristic of interest, 
with p<0.05 considered statistically significant. Since the goal of our analysis is to identify 
associations and generate hypotheses for future study, no adjustment for multiple 
comparisons was performed.23
RESULTS
We obtained data from all 105 active fixed-location breast imaging facilities across the six 
regional BCSC registries (Table 1). Of these, 81% of imaging facilities (85/105) provided 
information on for-profit status. Of the 85 facilities reporting profit status, 27.1% (23/85) 
had for-profit status and 72.9% (62/85) had not-for-profit status. Of the 105 facilities, 7.6% 
(8/105) were affiliated with an academic institution. The majority of facilities were full 
diagnostic radiology practices (66/105, 62.9%), followed by multi-specialty breast centers 
(25/105, 23.8%), non-radiology practices (10/105, 9.5%), and breast imaging only practices 
(4/105, 3.8%).
For-profit status and academic affiliation were not associated with availability of breast US 
or breast MRI at an individual facility (Table 2). However, availability of advanced breast 
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imaging services differed by type of practice. Specifically, all observed multi-specialty 
breast centers offered breast US, and full diagnostic practices were more likely to offer 
breast US than breast imaging only or non-radiology practices (81.8% vs. 50% and 22.2%, 
respectively, p<0.0001). Multi-specialty breast centers were significantly more likely to 
provide breast MRI services compared to full diagnostic radiology practices (76% versus 
39.1%, respectively, p = 0.024). None of the non-radiology and breast imaging only 
practices offered breast MRI services.
For supplemental screening indications, there was no statistically significant difference 
between for-profit status or academic status and the availability of advanced breast cancer 
screening modalities. Screening ultrasound and screening breast MRI were not available at 
any breast imaging only or non-radiology practice. While there was no statistically 
significant difference in availability of screening ultrasound at multi-specialty breast centers 
versus full diagnostic radiology practices, screening breast MRI was available at 56.0% of 
multi-specialty breast centers versus 18.8% of full diagnostic radiology practices (p = 
0.020).
For-profit imaging facilities were more likely to offer image-guided breast biopsies 
(p=0.028), including US-guided breast biopsies (p=0.03). However, there was no 
statistically significant relationship between for-profit status and the availability of the most 
lucrative biopsy procedure, MRI-guided breast biopsy (p=0.23). Instead, MRI-guided breast 
biopsy was available at 75.0% of facilities with an academic affiliation versus 24.0% of 
facilities without an academic affiliation (p=0.019). The availability of imaging-guided 
biopsy services was also related to practice type (p=0.011, for any imaging-guided biopsy) 
(Table 3). Specifically, multi-specialty breast centers were more likely to offer stereotactic, 
US-guided, and MRI-guided breast biopsy services compared to full diagnostic radiology 
practices (p = 0.0012, 0.0089, and 0.0063, respectively).
When assessing the availability of different combinations of advanced breast imaging 
modalities and/or image-guided breast biopsy services, there were no statistically significant 
associations between their availability and for-profit status of imaging facilities (Table 4). 
However, a combination of both screening breast US and screening breast MRI was more 
likely to be available at multi-specialty breast centers compared to full diagnostic radiology 
practices (28.0% versus 4.7%, p=0.0009) and facilities with an academic affiliation 
compared to those without an affiliation (25.0% versus 8.5%, p=0.022). In addition, a 
combination of breast US, breast MRI, and imaging-guided breast biopsy services was 
available at 76.0% of multi-specialty breast centers compared to 22.2% of full diagnostic 
radiology practices (p=0.0047) and 75.0% of facilities with academic affiliations compared 
to 29.0% of those without academic affiliations (p=0.041).
DISCUSSION
Our study, involving a large national sample of breast imaging facilities, demonstrated a 
significant association between screening facility characteristics and availability of advanced 
breast imaging modalities beyond mammography. Interestingly, the profit status of 
screening facilities was less strongly related to the availability of different advanced breast 
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imaging services than practice type and academic affiliation. To our knowledge, our study is 
the first to demonstrate a relationship between screening facility characteristics and the 
availability of on-site advanced breast imaging modalities.
Our findings may be important for referral of patients as attending multiple facilities for 
imaging purposes may result in delays in diagnosis, greater lost time and out-of-pocket 
expenses from added travel, potential repeat imaging with a change in institution, or 
potential medical errors with the transfer of clinical and imaging data between facilities.24 
We found that the type of practice women attend for mammography screening may 
influence their ability to readily access additional breast imaging required to complete 
diagnostic work-ups after abnormal screening. Specifically, women attending multi-
specialty breast centers and full diagnostic radiology practices for screening are more likely 
to have advanced breast imaging services readily available compared to women attending 
non-radiology or breast imaging only practices. Therefore, women attending such facilities 
are less likely to have to travel to another facility to obtain complete diagnostic evaluations 
prior to resolution of screening abnormalities or definitive treatment for screen-detected 
cancer.
The strong relationship between practice type and advanced breast imaging availability 
extends beyond availability of modalities for usual diagnostic evaluations. For women 
seeking supplemental screening, such as women with mammographically dense breasts or 
those at very high lifetime risk of developing cancer, screening breast US and screening 
breast MRI were more likely to be available at multi-specialty breast centers, followed by 
full diagnostic radiology practices. Screening breast US and screening breast MRI were also 
more likely to be available at facilities affiliated with academic medical centers.
Interestingly, many facilities offering diagnostic ultrasound and diagnostic breast MRI 
services did not offer screening ultrasound or screening breast MRI services. This was true 
across all categories of facilities, regardless of for-profit status, academic affiliation, or 
practice type. This finding suggests that other factors, such as financial reimbursement or 
adherence to screening guidelines and recommendations, may be affecting the on-site 
availability of supplemental breast cancer screening services. These other potential enabling 
characteristics should be included in future research studies examining advanced breast 
imaging availability.
Based on our analysis, patients seeking to obtain all of their breast imaging for the full 
potential breast care continuum at one location are most likely to find a combination of 
multiple advanced modalities and imaging-guided biopsy services at multi-specialty breast 
centers, followed by full diagnostic radiology practices. This association is important for 
providers and patients to be aware of, as women with screen-detected abnormalities that 
need diagnostic imaging and potentially biopsy may obtain more expedient care if they 
select to attend multi-specialty breast centers or full diagnostic radiology practices for 
screening, rather than non-radiology or breast imaging only practices. For women at high-
risk or with a personal history of breast cancer who obtain frequent screening breast MRI 
exams, MRI-guided biopsy is most likely available at facilities associated with an academic 
medical center.
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A major strength of our study is that it involves a large cohort of currently active breast 
imaging facilities with a patient population similar to that of the U.S.5,21 Furthermore, our 
analysis accounts for potential non-independence of facilities belonging to the same group 
practice. However, there were limitations to our study. First, some of the facilities offering 
screening mammography may have affiliations with diagnostic imaging centers apart from 
their own group practice or health system, still akin to a spoke-and-hub practice model for 
screening. Such affiliations are not accounted for in our analysis, but may still allow for 
timely access to advanced imaging modalities for both supplemental screening and 
diagnostic work-up after screening mammography. Second, we considered only the ready 
availability of breast US, breast MRI, and image-guided biopsy. We did not consider the 
ready availability of newer modalities, such as digital breast tomosynthesis and automated 
whole breast US, for which data were not available at the time of our analysis. Third, we did 
not evaluate advanced breast imaging availability based on the specific needs of the patient 
populations served. Finally, 19% of facilities did not report their for-profit status in order to 
protect their anonymity, which somewhat limits interpretation of the reported associations 
between for-profit status and availability of advanced imaging.
In conclusion, our analysis demonstrates that screening facility characteristics are strongly 
related to the availability of on-site advanced breast imaging capabilities. Women seeking 
supplemental screening or complete diagnostic evaluations at the same physical site as their 
screening mammogram may choose to be more discerning about what type of screening 
facility they choose to attend. Advanced breast imaging modalities and image-guided biopsy 
services are most likely to be found at facilities that are part of a multi-specialty breast 
center, followed by full diagnostic radiology practices, and then breast imaging only and 
non-radiology practices. Moreover, future studies evaluating the effects of access to breast 
cancer screening on patient outcomes should consider imaging facility-level characteristics 
such as practice type, as they may have important implications on timely diagnostic 
evaluation and prevention of potential delays to definitive treatment after abnormal 
screening.
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